RespireRx Pharmaceuticals Inc (RSPI)

[haysaw]

Really, freely? You are going to bottom feed a stock that is about 98% off its high? Surely you can find another penny with a more reliable track record. I think there are only two reasonable options here: Get out and stay out; or, get back in and wait for some type of lucky pop. The last financing down here (with Samyang) actually elevated the stock. It was the slow bleed, following the "hugely positive development for Cortex" (Neuro's take on the Biovail deal), which brought
Corx back down to its proverbial (weak) knees.